ESR1 and neoplasm: Taken together, these data lead to the hypothesis that a tumor with nuclear translocation of CYT-2-dominant 4ICD may reinforce ER-dependent growth in cooperation with ER transcriptional activity, which implies that these characteristics would be a useful index when choosing endocrine mono-therapy for ER+ HER2- patients.